ArticleMolecular and clinical oncology2015

Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.

Seyda Gündüz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.